Pharma

Your Article Summary

See Latest Articles

FDA Approves GARDASIL for Use in Boys and Young Men
Merck & Co., 10/19/09

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has approved GARDASIL for use in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus types 6 and 11. FDA approval is the first step in an important two–step process.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals